ECP was performed using the CELLEX Photopheresis System or the UVAR XTS Photopheresis System (Therakos, Inc, Exton, PA). (bvsalud.org)
Kamen-led DEKA teams have also developed critical components of the UVAR TM XTS TM System, an extracorporeal photophereisis device marketed by Therakos, a unit of Johnson & Johnson, for treatment of T-Cell lymphoma. (firstinspires.org)
THERAKOS4
Use of the THERAKOS ® UVAR and UVAR XTS ® Photopheresis Systems after oral administration of methoxsalen were previously approved for the treatment of Cutaneous T-Cell Lymphoma. (nih.gov)
UVADEX solution is U.S. Food and Drug Administration ( FDA )-approved for extracorporeal administration with the THERAKOS UVAR XTS ® or CELLEX Photopheresis System in the palliative treatment of the skin manifestations of Cutaneous T-Cell Lymphoma (CTCL) that is unresponsive to other forms of treatment. (mallinckrodt.com)
UVADEX (methoxsalen) Sterile Solution should be used only by physicians who have special competence in the diagnosis and treatment of cutaneous T-cell lymphoma and who have special training and experience in the THERAKOS UVAR XTS or THERAKOS CELLEX Photopheresis System. (mallinckrodt.com)
Background: The most common instruments used for extracorporeal photopheresis (ECP) treatment in the United States are the UVAR XTS and the CELLEX devices (Therakos, West Chester, PA). (wustl.edu)
System1
[ 6 ] Compared with the second-generation UVAR XTS system, it requires a lower volume of blood and less time to complete. (medscape.com)